Tag Archives: IVAX Pharmaceuticals

$112 million settlement: charged with kickbacks from drug company & recommending docs prescribe antipsychotic drug Risperdal

The U.S. Justice Department said that Johnson & Johnson’s kickbacks to Omnicare, the largest U.S. provider of pharmacy services to nursing homes, took multiple forms, including rebates that were conditioned on Omnicare engaging in an ‘Active Intervention Program’ for Risperdal and payments disguised as data purchase fees, educational grants, and fees to attend Omnicare meetings.